返回
Biophytis SA（BPTSY）價格
BPTSY 股價走勢圖
BPTSY 股利
Biophytis SA
$0
0%
$0
收盤價：Jan 23, 16:00:00 GMT-5
$0
0%
$0
盤後：Jan 23, 18:12:13 GMT-5
關鍵數據
前收市價
$0.5
開盤價
--
當日範圍
-
52週區間
-
交易量
--
平均成交量
72
每股盈餘 (TTM)
-16.54
股息收益率
--
市值
--
什麼是 BPTSY？
Biophytis SA operates as a clinical-stage biotechnology company. The company is headquartered in Paris, Ile-De-France and currently employs 18 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.
